Recent Updates
Recently added Catalysts
FULC Positive Sentiment

Fulcrum Therapeutics to Participate in Upcoming May Conferences

Thursday, May 8, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Fulcrum Therapeutics, a clinical-stage biopharmaceutical company, announced its participation in several upcoming conferences including the H.C. Wainwright BioConnect Investor Conference and the RBC Capital Markets Global Healthcare Conference. This engagement aims to enhance interaction with investors and stakeholders. The company will host a fireside chat, with a replay accessible on their website for 30 days following the event.
Price reaction · baseline $5.07 (2025-05-07 close) · hit after-hours · 1 other FULC headline(s) in the window, move may be shared
day 0 close
+6.7%
day 1
+5.9%
day 3 · peak
+14.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Management participation in reputable investor conferences
  • Opportunities to engage with investors and stakeholders
  • Increased visibility for Fulcrum Therapeutics in the market

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+32%
120-day peak, hindsight
Typical move
15.6%
average across 6 past catalysts
Cash runway
~59 mo
Minimal dilution risk
Lead asset
Pociredir
Phase 2 · Sickle Cell Disease

Full Press Release Details

CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that management will participate in the following conferences:
H.C. Wainwright BioConnect Investor Conference at NASDAQ
RBC Capital Markets Global Healthcare Conference
Fireside Chat at 3:35 pm ET, Participation link: HERE
The webcast of the fireside chat will be accessible by visiting the "Events and Presentations" section of Fulcrum Therapeutics’ website at https://ir.fulcrumtx.com/events-and-presentations. A replay of the webcasts will be available on Fulcrum Therapeutics’ website for at least 30 days following the presentations.
About Fulcrum Therapeutics

Frequently Asked Questions

What is the focus of Fulcrum Therapeutics?

Fulcrum Therapeutics specializes in developing small molecules for patients with genetically defined rare diseases.

Which conferences will Fulcrum Therapeutics participate in?

Fulcrum Therapeutics will attend the H.C. Wainwright BioConnect and RBC Capital Markets Global Healthcare conferences.

Where can I watch the fireside chat?

The fireside chat can be viewed via the 'Events and Presentations' section on Fulcrum's website.

How long will the webcast replay be available?

The replay of the webcasts will be accessible for at least 30 days after the events.

ShareAdd on Google
Tags: FULC Viatris Investor Conferences Healthcare Fulcrum Therapeutics biopharmaceuticals investor conferences rare diseases
Last updated: May 8, 2025

Biotech snapshot

Cash runway
$319M liquidity · $5M/mo burn
~59 mo
Minimal dilution risk
Lead asset
PociredirPhase 2
Sickle Cell Disease →

Catalyst track record

+32%
best trade around FULC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for FULC.

See every catalyst's timing & PoA →